What is Cymbalta?
In August 2004 the Food and Drug Administration approved Cymbalta (generic name: duloxetine). Cymbalta was developed by Eli Lilly and Company for use in the treatment of depression, generalized anxiety disorder, major depressive disorder, fibromyalgia, diabetic kidney disease, osteoarthritis, and neuropathic pain. Approval for Cymbalta’s use spanned from 2004-2010 in the treatment of depression (August 2004) to also approval for use in the treatment of chronic musculoskeletal pain (November 2010).
Cymbalta was developed by Eli Lilly and Company researchers David Wong, Joseph Krushinski, and David Robertson. The patent application was granted in 1990. The initial New Drug Application for Cymbalta, however, was filed with the Food and Drug Administration in 2001 but was declined as “not approvable due to significant cGMP (current Good Manufacturing Practice) violations at the finished-product manufacturing facility at the Eli Lilly location in Indianapolis. Once those issues were resolved,
What is Cymbalta prescribed for?
Cymbalta was approved for use in the treatment of diabetic neuropathy and depression in 2004. Subsequently, in 2007 Cymbalta was given the green light by Health Canada for use in the treatment of diabetic peripheral neuropathic pain and depression.
How does Cymbalta Work?
Cymbalta is a norepinephrine reuptake inhibitor and a selective serotonin. Norepinephrine acts as both a neurotransmitter and a hormone. It works on the area of the brain that responds to stress, mood, emotions, pain, blood pressure, and cognition, to relieve stress and pain, thereby easiong many other conditions and symptoms. Serotonin is a neurotransmitter which occurs naturally and which affects pain perception, mood regulation, and other physical functions. All of these properties work together to block the “messages” the body is sending to the brain receptors, alleviating pain before it can get a foothold.
Cymbalta has also been shown to have analgesic properties and helps control pain related to bone issues, fibromyalgia, and diabetic neuropathy.
Help with the cost of Cymbalta…
Not many people know that a number of Pharmaceutical companies run programs called the Patient Assistance Programs or prescription assistance programs. These programs are designed to help people with low income and little to no prescription insurance coverage by providing the medications at little or no money.
We bring together our nation’s largest pharmaceutical companies along with other medical professionals to help patients qualify for such programs for very low monthly fees. Our mission is to spread awareness of such programs and help eligible people get into such programs easily and without hassle.
If you need help with the cost of Cymbalta, call us today at (888) 823-0042 to enroll in our widely successful program. Join us today and let us lend you a helping hand.